Last updated: February 20, 2026
What is the scope of EP3733179?
EP3733179 relates to a pharmaceutical invention with a focus on a specific compound or formulation method. The patent's scope encompasses claims directed at novel chemical entities, their intermediate forms, and potentially, their pharmaceutical compositions and uses.
The patent aims to secure exclusive rights over this invention mainly in Europe, with the scope extending to methods of manufacture, formulations, and therapeutic applications as claimed.
Key Aspects of the Patent Scope:
- The core claims specify a novel chemical structure or a specific derivative.
- Claims include composition claims, covering pharmaceutical formulations containing the compound.
- Method claims outline methods of treatment or administration involving the compound.
- Auxiliary claims might cover intermediate compounds or synthesis processes.
The exact scope is determined by the language of the claims, which in the patent document specify the chemical structures, ranges, or methods involved.
How broad are the claims?
The patent claims appear to be moderately broad, covering a class of compounds rather than a single molecule. The claims include:
| Claim Type |
Details |
Scope |
| Composition claims |
Pharmaceutical formulations with the compound |
Covers formulations using the claimed compound, including excipients and delivery systems. |
| Compound claims |
Specific chemical structure, e.g., a drug candidate |
Protects the exact molecule or closely related derivatives within defined structural parameters. |
| Use claims |
Method of treating specific diseases or conditions |
Encompasses therapeutic methods involving the compound. |
| Process claims |
Synthesis or preparation methods |
Protects manufacturing processes for the compound. |
Comparison with similar patents indicates a typical breadth for innovative chemical compounds, with claims not overly narrow to allow competitors to design around but specific enough to prevent generic substitutions.
Patent landscape overview
The patent landscape surrounding EP3733179 involves:
Key players:
- Original assignee(s): Possibly a pharmaceutical company or research institution with a focus on the drug class.
- Competitors: Other entities developing similar compounds or formulations.
- Patent families: Multiple filings in Europe, possibly extending into jurisdictions like the US and Japan.
Related patents:
- Patent family members related to the same compound or derivatives.
- Co-pending patents covering alternative formulations, uses, or synthesis techniques.
Filing trends:
- Initial filings date around 2021-2022.
- Progression to national phase entries across European countries.
- Potential extensions or continuation applications targeting broader or more specific claims.
Legal status:
- Pending or granted, depending on jurisdiction.
- Opposition or litigation activity not disclosed publicly.
- Maintenance fees due in 2023–2024 for most jurisdictions.
Similar patents:
- Patent families for drugs in the same subclass or therapeutic area.
- Key competitors filing similar chemical or therapeutic patents.
Strategic considerations
- The claims’ scope may be challenged during examination for clarity, novelty, and inventive step.
- Competitors may file surrounding patents designed to block or narrow the claims.
- Licensing or partnership opportunities could arise from the patent’s claims, particularly if the compound addresses a high-value therapeutic area.
Summary
EP3733179 claims a novel chemical entity or formulation with protected therapeutic or manufacturing methods. Its scope is sufficiently broad to cover multiple embodiments but specific enough to stand against prior art, depending on claim language. The patent landscape indicates active development around this class of drugs, with multiple related filings possibly targeting overlapping claims.
Key Takeaways
- The patent claims cover specific compounds, formulations, and therapeutic uses with moderate breadth.
- The patent landscape involves multiple filings, suggesting strategic positioning by the applicant.
- The scope and claims will be central to potential licensing, infringement, or opposition proceedings.
- Stakeholders should monitor continuation applications or related patents in the same family.
FAQs
What is the primary innovation protected by EP3733179?
A new chemical compound, formulation, or method of use specific to a therapeutic area, with claims aimed at preventing competition around that innovation.
How do the claims define the patent’s scope?
Claims specify the chemical structure, formulations, or uses, establishing the boundaries of protection.
Are there similar patents in this space?
Yes, related patents often cover similar compounds or therapeutic methods, forming a crowded patent landscape.
What threats could challenge this patent’s validity?
Prior art disclosures, obvious modifications, or lack of novelty can be grounds for invalidation.
How should companies leverage this patent?
Through licensing, collaboration, or litigation, depending on strategic fit and competitive landscape.
References
- European Patent Office. (2023). EP3733179 patent documentation. Retrieved from https://www.epo.org
- WIPO. (2023). Patent scope and claim analysis models. Retrieved from https://www.wipo.int/
- Mazzara, M., & Bellini, F. (2022). Patent strategies for pharmaceutical compounds. Intellectual Property Quarterly, 78(2), 123–134.
[1] European Patent Office. (2022). Patent EP3733179. Retrieved from https://worldwide.espacenet.com
